Clinical trial
A Randomized and Double-blind Clinical Trial of Guishen Yijing Granules on the Modulation of Ovarian Function in Patients With Diminished Ovarian Reserve
NCT07841548 is registered in ClinicalTrials.gov with Shi Yun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized and Double-blind Clinical Trial of Guishen Yijing Granules on the Modulation of Ovarian Function in Patients With Diminished Ovarian Reserve
- Lead sponsor
- Shi Yun
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 22, 2026
- Completion date
- December 31, 2027
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diminished ovarian reserve (dor)